Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
About Us
Contact
Services
Institutions
Market Impact Report
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
About Us
Contact
Services
Institutions
Market Impact Report
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
DPLO
News
DPLO –
diplomat pharmacy inc
(US:NYSE)
DELAYED
$
usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DPLO
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
9/12
02:03 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating.
Low
8/30
04:05 pm
dplo
Diplomat to Participate in Upcoming Investor Conferences
Low
8/9
04:40 pm
dplo
Diplomat Pharmacy's Stronger Top Line Doesn't Help Its Bottom Line [The Motley Fool]
Low
8/7
06:40 pm
dplo
Diplomat Pharmacy (DPLO) Q2 2018 Earnings Conference Call Transcript [The Motley Fool]
Low
8/6
09:53 pm
dplo
Diplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q2 2018 Results - Earnings Call Transcript [Seeking Alpha]
Low
8/6
08:01 pm
dplo
Diplomat Pharmacy 2018 Q2 - Results - Earnings Call Slides [Seeking Alpha]
Low
8/6
06:43 pm
dplo
Diplomat Pharmacy 2018 Q2 - Results - Earnings Call Slides [Seeking Alpha]
Low
8/6
04:29 pm
dplo
Diplomat Pharmacy misses by $0.06, revenue in-line [Seeking Alpha]
Medium
8/6
04:15 pm
dplo
Diplomat Announces 2nd Quarter Financial Results
Medium
7/23
07:45 am
dplo
Diplomat to Release Second-Quarter 2018 Operating Results, Host Conference Call on Aug. 6
Low
7/20
04:40 pm
dplo
Why Diplomat Pharmacy, Inc. Stock Dropped 10.4% Today [The Motley Fool]
Low
7/3
08:30 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) had its price target raised by analysts at Morgan Stanley from $16.00 to $21.00. They now have an "equal weight" rating on the stock.
Low
6/22
07:26 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) had its "outperform" rating re-affirmed by analysts at Leerink Swann. They now have a $33.00 price target on the stock.
Low
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
Measuring the News: A Look at NewsQuantified's Stock Impact Reports
NQ Founder to Appear on Expert Investing Panel | Sign Up for Live Event
Bloomberg Sees "End of Disco" for Traditional Fund Managers
How Can Retail Investors Succeed in the "Money Manager" Era of Capitalism?
Friday Roundup + Top Performer: Currency Crises Simmer, U.S. Consumer Economy Chugs Forward